e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Natural history of COPD: novel aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic values of biomarkers in COPD
A. Agusti (Barcelona, Spain)
Source:
Annual Congress 2013 –Natural history of COPD: novel aspects
Session:
Natural history of COPD: novel aspects
Session type:
Symposium
Number:
5004
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Agusti (Barcelona, Spain). Prognostic values of biomarkers in COPD. Annual Congress 2013 –Natural history of COPD: novel aspects
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Prognostic assessment in COPD without lung function: the B-AE-D indices
Source: Eur Respir J 2016; 47:1635-1644
Year: 2016
Prognostic features of disability in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 57s
Year: 2004
Prognostic evaluation of COPD patients with pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 257s
Year: 2005
Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Prognostic nutritional index (PNI): A predictive factor for elderly patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
Prognostic parameters in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006
Prognostic predictors for survival in patients with COPD using cardiopulmonary testing
Source: Eur Respir J 2002; 20: Suppl. 38, 285s
Year: 2002
Prognostic significance of surrogate measures for FVC in an elderly population
Source: Annual Congress 2008 - Asthma and miscellaneous disorders
Year: 2008
Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014
Prognostic predictors of course sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 45s
Year: 2003
Prognostic and predictive factors for lung cancer
Source: Breathe 2012; 9: 112-122
Year: 2012
Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis
Source: ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020
Year: 2021
Clinical prognostic tools and their use in COPD.
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
The prognostic value of extended lung function characterization in COPD
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept